High Entrapment Efficiency : We utilize advanced loading techniques to maximize the amount of GHK-Cu inside the liposomes, reducing waste and ensuring a potent final product
In 2026, the pace of scientific discovery is relentless
Anecdotal reports show AOD-9604 boasts fat-burning properties that enhance metabolism
Key Safety Differentiators No IGF-1 elevation: AOD-9604 does not stimulate IGF-1, meaning it avoids risks such as organ/tissue overgrowth or acromegaly No glucose disruption: Clinical data shows it does not impair insulin sensitivity or worsen blood sugar regulation Comparable to placebo: In obesity trials, the incidence of adverse effects was similar to placebo groups, underscoring its tolerability Legal Status of AOD-9604 United States: AOD-9604 is not FDA-approved as a drug, dietary supplement, or weight loss therapy
Any use beyond controlled laboratory research, including introduction into humans or animals, is strictly prohibited